Oribel Capital Management’s Flex FLEX Stock Holding History

Oribel Capital Management’s Portfolio FLEX Stock Details FLEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.8M	Sell	362,500 -51,700	-12%	-$6.27M	1.78%	13
2026 Q1	$27.1M	Buy	414,200 +269,800	+187%	+$17.3M	1.2%	26
2025 Q4	$8.72M	Buy	+144,400	New	+$8.92M	0.4%	82

Other funds holding FLEX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Oribel Capital Management's FLEX Position: Q2 2026 in Review

Oribel Capital Management reduced its Flex (FLEX) stake by 12% in Q2 2026, selling an estimated $6.27M and leaving 362,500 shares worth $58.8M. The position accounts for 1.78% of the portfolio, ranked #12.

Oribel Capital Management first reported a position in FLEX in Q2 2017 and has held it in 10 quarters since. 1,116 funds tracked by Wall St. Rank hold FLEX as of Q2 2026.

Oribel Capital Management held 362,500 shares of Flex worth $58.8M as of Q2 2026.
Oribel Capital Management sold 51,700 Flex shares in Q2 2026, an estimated $6.27M.
Flex made up 1.78% of Oribel Capital Management's portfolio in Q2 2026, its #12 holding.
Oribel Capital Management first reported a position in Flex in Q2 2017 and has held it in 10 quarters since.
1,116 funds tracked by Wall St. Rank held Flex as of Q2 2026.

Based on Oribel Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.